Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03705260 · ClinicalTrials.gov registry record · NA
Quality Initiative to Improve Glucose Control in Type 2 Diabetic Patients
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 64
- Enrollment target
NCT03705260: Completed NA study, sponsored by University of Michigan.
NCT03705260 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03705260, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 64 participants
- Enrollment target
Study Summary
The goal of the Twine / University of Michigan Diabetes Quality Improvement Initiative is to improve diabetes care quality using real time feedback with continuous glucose monitoring (CGM) and dietary coaching for lower carbohydrate consumption in a high-risk sub-cohort of outpatients with type 2 diabetes (T2D).
Primary Outcome
Hemoglobin A1C
Interventions
- OTHER Usual Care
- BEHAVIORAL Intensive Behavioral Intervention
- OTHER Monthly Screening for Risk
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2018-11-26 |
| Est. Completion | 2021-01-20 |
| Phase | NA |
What the finished NCT03705260 record still lists
NCT03705260 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 3 interventions - of which Usual Care is the first listed.
NCT03705260 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03705260 about?
NCT03705260 is a clinical study titled "Quality Initiative to Improve Glucose Control in Type 2 Diabetic Patients". The goal of the Twine / University of Michigan Diabetes Quality Improvement Initiative is to improve diabetes care quality using real time feedback with continuous glucose monitoring (CGM) and dietary coaching for lower carbohydrate consumption in a high-risk sub-cohort of outpatients with type 2 di...
What is the current status of trial NCT03705260?
This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2018-11-26. Estimated completion is 2021-01-20.
What interventions are being tested in trial NCT03705260?
The interventions under investigation include: Usual Care (OTHER), Intensive Behavioral Intervention (BEHAVIORAL), Monthly Screening for Risk (OTHER).
Who is sponsoring clinical trial NCT03705260?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03705260's enrollment target sits among peer trials
64 1147th of 2000 higher than 844 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI